Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Parkinson’s disease and related disorders

Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Parkinson's Disease Collaborators

Originally published in The Lancet. Neurology · 2018-10-01

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Background Neurological disorders are now the leading source of disability globally, and ageing is increasing the burden of neurodegenerative disorders, including Parkinson's disease. We aimed to determine the global burden of Parkinson's disease between 1990 and 2016 to identify trends and to enable appropriate public health, medical, and scientific responses. Methods Through a systematic analysis of epidemiological studies, we estimated global, regional, and country-specific prevalence and years of life lived with disability for Parkinson's disease from 1990 to 2016. We estimated the proportion of mild, moderate, and severe Parkinson's disease on the basis of studies that used the Hoehn and Yahr scale and assigned disability weights to each level. We jointly modelled prevalence and excess mortality risk in a natural history model to derive estimates of deaths due to Parkinson's disease. Death counts were multiplied by values from the Global Burden of Disease study's standard life expectancy to compute years of life lost. Disability-adjusted life-years (DALYs) were computed as the sum of years lived with disability and years of life lost.

Results

Globally, Parkinson's disease caused 211 296 deaths (95% UI 167 771–265 160; 93 512, 95% UI 73 702–118 421, in women and 117 784, 93 729–147 607, in men) and 3·2 million DALYs (95% UI 2·6–4·0; 1·4 million, 95% UI 1·1–1·7, in women; 1·8 million, 1·5–2·3, in men) in 2016. Of these, high SDI countries accounted for 84 911 (40·2%) deaths and 1·1 million (34·4%) DALYs, high-middle or middle SDI countries for 98 820 (46·8%) deaths and 1·6 million (50·0%) DALYs, and low-middle or low SDI countries for 27 470 (13·0%) deaths and 0·5 million (15·6%) DALYs.

Discussion

Over the past generation, the number of individuals with Parkinson's disease globally has more than doubled to over 6 million. Of all the neurological disorders included in GBD 2015,1 Parkinson's disease was the fastest growing. Ageing populations contributed to much of that growth as crude prevalence rates increased by about 74% from 1990 to 2016 and age-standardised prevalence rates increased by about 22%. However, because age-standardised prevalence, DALYs, and death rates all increased from 1990 to 2016, additional factors are probably important.

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?